Skip to main content
Erschienen in: Metabolic Brain Disease 2/2009

01.06.2009 | Original Paper

NAD metabolism in HPRT-deficient mice

verfasst von: Vanna Micheli, Gabriella Jacomelli, Federica Di Marcello, Laura Notarantonio, Silvia Sestini, Barbara Cerboni, Matteo Bertelli, Giuseppe Pompucci, Hyder A. Jinnah

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

The activity of hypoxanthine-guanine phosphoribosyltransferase (HPRT) is virtually absent in Lesch-Nyhan disease (LND), an X-linked genetic disorder characterized by uric acid accumulation and neurodevelopmental dysfunction. The biochemical basis for the neurological and behavioral abnormalities have not yet been completely explained. Prior studies of cells from affected patients have shown abnormalities of NAD metabolism. In the current studies, NAD metabolism was evaluated in HPRT gene knock-out mice. NAD content and the activities of the enzymes required for synthesis and breakdown of this coenzyme were investigated in blood, brain and liver of HPRT- and control mice. NAD concentration and enzyme activities were found to be significantly increased in liver, but not in brain or blood of the HPRT- mice. These results demonstrate that changes in NAD metabolism occur in response to HPRT deficiency depending on both species and tissue type.
Literatur
Zurück zum Zitat Adams A, Harkness RA (1976) Developmental changes in purine phosphoribosyltransferases in human and rat tissues. Biochem J 160:565–576PubMed Adams A, Harkness RA (1976) Developmental changes in purine phosphoribosyltransferases in human and rat tissues. Biochem J 160:565–576PubMed
Zurück zum Zitat Allen SM, Davis WM (1999) Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome. Behav Pharmacol 10:467–474PubMedCrossRef Allen SM, Davis WM (1999) Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome. Behav Pharmacol 10:467–474PubMedCrossRef
Zurück zum Zitat Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–265PubMedCrossRef Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–265PubMedCrossRef
Zurück zum Zitat Cappiello M, Vilardo PG, Micheli V, Jacomelli G, Banditelli S, Leverenz V, Giblin FJ, Del Corso A, Mura U (2000) Thiol-disulfide exchange modulates the activity of aldose reductase in intact bovine lens as a response to oxidative stress. Exp Eye Res 70:795–803PubMedCrossRef Cappiello M, Vilardo PG, Micheli V, Jacomelli G, Banditelli S, Leverenz V, Giblin FJ, Del Corso A, Mura U (2000) Thiol-disulfide exchange modulates the activity of aldose reductase in intact bovine lens as a response to oxidative stress. Exp Eye Res 70:795–803PubMedCrossRef
Zurück zum Zitat Cerboni B, Micheli V, Jacomelli G, Notarantonio L, Pompucci G, Sestini S (2007) NAD glycohydrolase activity in Lesch-Nyhan erythrocytes. Abstract book XII International Symposium on Purine and Pyrimidine Metabolism in Man. Chicago, IL, USA, p 66 Cerboni B, Micheli V, Jacomelli G, Notarantonio L, Pompucci G, Sestini S (2007) NAD glycohydrolase activity in Lesch-Nyhan erythrocytes. Abstract book XII International Symposium on Purine and Pyrimidine Metabolism in Man. Chicago, IL, USA, p 66
Zurück zum Zitat Clark M, Dar MSJ (1988) The effects of various methods of sacrifice and of ethanol on adenosine levels in selected areas of rat brain. Neurosci Methods 25:243–249CrossRef Clark M, Dar MSJ (1988) The effects of various methods of sacrifice and of ethanol on adenosine levels in selected areas of rat brain. Neurosci Methods 25:243–249CrossRef
Zurück zum Zitat Engle SJ, Womer DE, Davies PM, Boivin G, Sahota A, Simmonds HA, Stambrook PJ, Tischfield JA (1996) HPRT-APRT-deficient mice are not a model for Lesch-Nyhan syndrome. Hum Mol Genet 5:1607–1610PubMedCrossRef Engle SJ, Womer DE, Davies PM, Boivin G, Sahota A, Simmonds HA, Stambrook PJ, Tischfield JA (1996) HPRT-APRT-deficient mice are not a model for Lesch-Nyhan syndrome. Hum Mol Genet 5:1607–1610PubMedCrossRef
Zurück zum Zitat Fairbanks LD, Jacomelli G, Micheli V, Slade T, Simmonds HA (2002) Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. Biochem J 366:265–272PubMed Fairbanks LD, Jacomelli G, Micheli V, Slade T, Simmonds HA (2002) Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. Biochem J 366:265–272PubMed
Zurück zum Zitat Foster AC, Whetsell WO Jr, Bird ED, Schwarcz R (1985) Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res 336:207–214PubMedCrossRef Foster AC, Whetsell WO Jr, Bird ED, Schwarcz R (1985) Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res 336:207–214PubMedCrossRef
Zurück zum Zitat Jinnah HA, Langlais PJ, Friedmann T (1992) Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. J Pharmacol Exp Ther 263:596–607PubMed Jinnah HA, Langlais PJ, Friedmann T (1992) Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. J Pharmacol Exp Ther 263:596–607PubMed
Zurück zum Zitat Jinnah HA, Page T, Friedmann T (1993) Brain purines in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 60:2036–2045PubMedCrossRef Jinnah HA, Page T, Friedmann T (1993) Brain purines in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 60:2036–2045PubMedCrossRef
Zurück zum Zitat Jinnah HA, Wojcik BE, Hunt M, Narang N, Lee KY, Goldstein M, Wamsley JK, Langlais PJ, Friedmann T (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci 14:1164–1175PubMed Jinnah HA, Wojcik BE, Hunt M, Narang N, Lee KY, Goldstein M, Wamsley JK, Langlais PJ, Friedmann T (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci 14:1164–1175PubMed
Zurück zum Zitat Jinnah HA, Jones MD, Wojcik BE, Rothstein JD, Hess EJ, Friedmann T, Breese GR (1999) Influence of age and strain on striatal dopamine loss in a genetic mouse model of L.N. disease. J Neurochem 72:225–229PubMedCrossRef Jinnah HA, Jones MD, Wojcik BE, Rothstein JD, Hess EJ, Friedmann T, Breese GR (1999) Influence of age and strain on striatal dopamine loss in a genetic mouse model of L.N. disease. J Neurochem 72:225–229PubMedCrossRef
Zurück zum Zitat Jinnah HA, De Gregorio L, Harris JC, Nyhan WL, O'Neill JP (2000) The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res 463:309–326PubMedCrossRef Jinnah HA, De Gregorio L, Harris JC, Nyhan WL, O'Neill JP (2000) The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res 463:309–326PubMedCrossRef
Zurück zum Zitat Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, Gonzalez-Alegre P, Neychev V, Torres RJ, Dulac O, Desguerre I, Schretlen DJ, Robey KL, Barabas G, Bloem BR, Nyhan W, De Kremer R, Eddey GE, Puig JG, Reich SG et al (2006) Delineation of the motor disorder of Lesch-Nyhan disease. Brain 129:1201–1217PubMedCrossRef Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, Gonzalez-Alegre P, Neychev V, Torres RJ, Dulac O, Desguerre I, Schretlen DJ, Robey KL, Barabas G, Bloem BR, Nyhan W, De Kremer R, Eddey GE, Puig JG, Reich SG et al (2006) Delineation of the motor disorder of Lesch-Nyhan disease. Brain 129:1201–1217PubMedCrossRef
Zurück zum Zitat Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36:561–570PubMedCrossRef Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36:561–570PubMedCrossRef
Zurück zum Zitat Micheli V, Sestini S (1997) Determining NAD synthesis in erythrocytes. In: McCormick DB, Suttie JW, Wagner C (eds) Methods in Enzymology, vol 280. vitamins and coenzymes. Academic Press Inc., Orlando, Florida, pp 211–221 Micheli V, Sestini S (1997) Determining NAD synthesis in erythrocytes. In: McCormick DB, Suttie JW, Wagner C (eds) Methods in Enzymology, vol 280. vitamins and coenzymes. Academic Press Inc., Orlando, Florida, pp 211–221
Zurück zum Zitat Micheli V, Sestini S, Rocchigiani M, Jacomelli G, Manzoni F, Peruzzi L, Gathof BS, Zammarchi E, Pompucci G (1999) Hypoxanthine-guanine phosphoribosyltransferase deficiency and erythrocyte synthesis of pyridine coenzymes. Life Sci 64:2479–2487PubMedCrossRef Micheli V, Sestini S, Rocchigiani M, Jacomelli G, Manzoni F, Peruzzi L, Gathof BS, Zammarchi E, Pompucci G (1999) Hypoxanthine-guanine phosphoribosyltransferase deficiency and erythrocyte synthesis of pyridine coenzymes. Life Sci 64:2479–2487PubMedCrossRef
Zurück zum Zitat Micheli V, Simmonds HA, Bari M, Pompucci G (1993) HPLC determination of oxidized and reduced coenzymes in human erythrocytes. Clin Chim Acta 220:1–17PubMedCrossRef Micheli V, Simmonds HA, Bari M, Pompucci G (1993) HPLC determination of oxidized and reduced coenzymes in human erythrocytes. Clin Chim Acta 220:1–17PubMedCrossRef
Zurück zum Zitat Nyhan WL, Wong DF (1996) New approach to understandyng Lesch-Nyhan disease. New Engl J Med 334(24):1602–1604PubMedCrossRef Nyhan WL, Wong DF (1996) New approach to understandyng Lesch-Nyhan disease. New Engl J Med 334(24):1602–1604PubMedCrossRef
Zurück zum Zitat Pesi R, Micheli V, Jacomelli G, Peruzzi L, Camici M, Garcia-Gil M, Allegrini S, Tozzi MG (2000) Cytosolic 5’-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. Neuroreports 11:173–177CrossRef Pesi R, Micheli V, Jacomelli G, Peruzzi L, Camici M, Garcia-Gil M, Allegrini S, Tozzi MG (2000) Cytosolic 5’-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. Neuroreports 11:173–177CrossRef
Zurück zum Zitat Sestini S, Jacomelli G, Pescaglini M, Micheli V, Pompucci G (2000) Enzyme activities leading to NAD synthesis in human lymphocytes. Archives Biochem Biophys 379:277–282CrossRef Sestini S, Jacomelli G, Pescaglini M, Micheli V, Pompucci G (2000) Enzyme activities leading to NAD synthesis in human lymphocytes. Archives Biochem Biophys 379:277–282CrossRef
Zurück zum Zitat Shirley TL, Lewers JC, Egami K, Majumdar A, Kelly M, Ceballos-Picot I, Seidman MM, Jinnah HA (2007) A human neuronal tissue culture model for Lesch-Nyhan disease. J Neurochem 101:841–853PubMedCrossRef Shirley TL, Lewers JC, Egami K, Majumdar A, Kelly M, Ceballos-Picot I, Seidman MM, Jinnah HA (2007) A human neuronal tissue culture model for Lesch-Nyhan disease. J Neurochem 101:841–853PubMedCrossRef
Zurück zum Zitat Simmonds HA, Fairbanks LD, Morris GS, Webster DR, Harley EH (1988) Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism. Clin Chim Acta 171:197–210PubMedCrossRef Simmonds HA, Fairbanks LD, Morris GS, Webster DR, Harley EH (1988) Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism. Clin Chim Acta 171:197–210PubMedCrossRef
Zurück zum Zitat Wu CL, Melton DW (1993) Production of a model for Lesch-Nyhan syndrome in HPRT deficient mice. Nature Genet 3:235–240PubMedCrossRef Wu CL, Melton DW (1993) Production of a model for Lesch-Nyhan syndrome in HPRT deficient mice. Nature Genet 3:235–240PubMedCrossRef
Zurück zum Zitat Ziegler M (2000) New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 267:1550–1564 Ziegler M (2000) New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 267:1550–1564
Metadaten
Titel
NAD metabolism in HPRT-deficient mice
verfasst von
Vanna Micheli
Gabriella Jacomelli
Federica Di Marcello
Laura Notarantonio
Silvia Sestini
Barbara Cerboni
Matteo Bertelli
Giuseppe Pompucci
Hyder A. Jinnah
Publikationsdatum
01.06.2009
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2009
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-009-9134-9

Weitere Artikel der Ausgabe 2/2009

Metabolic Brain Disease 2/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.